Keyword: Prescription Medicines Code of Practice Authority
The U.K.’s promotional police cracked down on biosimilar marketing this week, citing Pfizer’s Hospira unit and Napp Pharmaceuticals for code violations at meetings they hosted for healthcare providers.
Doctors aren't getting the skinny on drug side effects from pharma reps, a new study finds. Even the most serious risks are often overlooked, the survey found. And while probes of off-label marketing abound, enforcement of risk disclosures during sales visits is mostly absent.